Ex-situ biological hydrogen methanation in trickle bed reactors : Integration into biogas production facilities

Biological hydrogen methanation (BHM) is a biocatalytic process for biogas upgrading. Integrating ex-situ BHM processes into biogas facilities has the advantage of using inoculum, CO2, and nutrients directly from anaerobic digestion (AD) processes to enhance CH4 productivity. This study investigated the potential of biowaste digestate as an inoculum and digested biowaste reject water as the trickling liquid and nutrient source in thermophilic trickle bed reactors (TBRs). Use of reject water improved H2 conversion efficiency to up to 99 %, thus achieving a H2 loading rate of 10.8 LH2 L Rv-1 d-1 at a gas retention time (GRT) of 1.8 h and CH4 productivity of 2.6 L LRv-1 d-1 implying that reject water contains macronutrients beneficial to enriching hydrogenotrophic methanogens. However, at high H2 loading rates, a trace element supply was necessary to stabilize process performance. Hydrogenotrophic methanogens Methanothermobacter and Methanobacterium were selectively enriched, mainly due to the increased H2 loading rate.publishedVersionPeer reviewe

Functionalization of TiO2 inverse opal structure with atomic layer deposition grown Cu for photocatalytic and antibacterial applications

TiO2 inverse opal (IO) structure surfaces were functionalized with a sub-monolayer amount of Cu by atomic layer deposition (ALD) and tested for photocatalytic and antimicrobial applications. Decomposition of acetylene (C2H2) into CO2 and reduction of CO2 into CH4 were tested in the gas phase and photodegradation of methylene blue (MB) was tested in the liquid phase. Antimicrobial activity was tested against Gram-positive Staphylococcus aureus (S. aureus) bacteria. ALD Cu without any post-deposition heat treatment (HT) decreased the photo degradation rate of both C2H2 and MB but improved the activity towards CO2 reduction. ALD Cu increased MB photodegradation rate and antimicrobial activity only after HT at 550 C, which was linked to the improved chemical stability Cu after the HT. The same HT decreased the activity towards CO2 reduction and decomposition of C2H2. The HT induced desorption of loosely bound ALD Cu+/2+ from the TiO2 IO surface and the remaining Cu+/2+ was reduced to Cu+. The photocatalytic and antimicrobial activity of TiO2 IO can be tailored by the addition of a sub-monolayer amounts of Cu with performance depending on the targeted reaction

Heparin-Derived Theranostic Nanoprobes Overcome the Blood-Brain Barrier and Target Glioma in Murine Model

The poor permeability of theranostic agents across the blood-brain barrier (BBB) significantly hampers the development of new treatment modalities for neurological diseases. A new biomimetic nanocarrier is discovered using heparin (HP) that effectively passes the BBB and targets glioblastoma. Specifically, HP-coated gold nanoparticles (HP-AuNPs) are designed that are labeled with three different imaging modalities namely, fluorescein (FITC-HP-AuNP), radioisotope (68)Gallium (Ga-68-HP-AuNPs), and MRI active gadolinium (Gd-HP-AuNPs). The systemic infusion of FITC-HP-AuNPs in three different mouse strains (C57BL/6JRj, FVB, and NMRI-nude) displays excellent penetration and reveals uniform distribution of fluorescent particles in the brain parenchyma (69-86%) with some accumulation in neurons (8-18%) and microglia (4-10%). Tail-vein administration of radiolabeled Ga-68-HP-AuNPs in healthy rats also show Ga-68-HP-AuNP inside the brain parenchyma and in areas containing cerebrospinal fluid, such as the lateral ventricles, the cerebellum, and brain stem. Finally, tail-vein administration of Gd-HP-AuNPs (that displays approximate to threefold higher relaxivity than that of commercial Gd-DTPA) in an orthotopic glioblastoma (U87MG xenograft) model in nude mice demonstrates enrichment of T1-contrast at the intracranial tumor with a gradual increase in the contrast in the tumor region between 1 and 3 h. It is believed, the finding offers the untapped potential of HP-derived-NPs to deliver cargo molecules for treating neurological disorders.Peer reviewe